• Net sales
  • Results
  • Cashflow
  • Share
  • Investments/​R&D
  • Currency effects
Net sales
Results
Cashflow
Share
Investments/​R&D expenditures
Currency effects

Net sales +3.5% Organic, currency-adjusted net sales growth in 2017

Chart is loading ...
Chart is loading ...
*Adjusted for costs in connection with the Sanitec acquisition and integration
Chart is loading ...
* Adjusted for costs in connection with the Sanitec acquisition and integration

Adjusted operating cashflow margin
(EBITDA margin) 28.2% 0.1 percentage higher than prior year

Free cashflow
(in CHF) 483 mio. -13.2% versus prior year

Adjusted earnings per share
(in CHF) 16.43 +3.7% versus prior year

Payout ratio

63.4% The payout ratio is in the upper range of the target corridor of 50 to 70%

Investments in property, plant and equipment and intangible assets
(in CHF) 159 mio. +14.3% versus prior year

R&D expenditures
(in CHF)

78 mio. +6 million versus prior year

Currency effects in EBIT
(in CHF) 8 mio.

Currency effects in net sales
(in CHF) 34 mio.